Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
AI Could Reshape Clinical Trials—and the Business of Pharma
GSK to pay $50M to use Noetik’s AI cancer models
GSK Licenses Noetik’s AI Foundation Models in Anchor Partnership to Transform Cancer Therapeutic Research and Development
The biggest scientific breakthroughs of the last 25 years—and a few to watch
NeurIPS 2025: Biology’s Transformer Moment
The Rarest of All Diseases Are Becoming Treatable
What’s next for AlphaFold: A conversation with a Google DeepMind Nobel laureate
How your body could outlive the genome you were born with
Retro Biosciences wants to add 10 healthy years to your life
Fierce Biotech’s 2025 Fierce 15
Jennifer Doudna on Medical Innovation | The Atlantic Festival 2025
The Billionaires Fueling the Quest for Longer Life
Making Personalized Crispr Cures to Save More Babies
Synthetic proteins are being built with the help of AI models
Dealmakers back AI drug discovery boom
The Hidden Barriers Holding Back Cancer’s Most Promising Treatments
Supercomputer named after Nobel laureate Jennifer Doudna
Baby Is Healed With World’s First Personalized Gene-Editing Treatment
TIME 100 Most Influential People of 2025
The Age of CRISPR
Sam Altman-backed Retro Biosciences to raise $1bn for project to extend human life
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Using AI to design small molecule drugs is tough. Here are five companies trying to crack the code.
Combining AI and Crispr Will Be Transformational
Ataraxis AI Launches to Transform Precision Medicine Beginning with World’s First AI-native Cancer Diagnostic
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing
With AI warning, Nobel winner joins ranks of laureates who’ve cautioned about the risks of their own work
Augmenting Humans: From bionic limbs, to smart skin and robot helpers
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement
The small-town Nobel Prize winner who wants to cure Alzheimer’s in 10 years
10 Most Innovative People of the Last 10 Years
Fareed Zakaria GPS: The gene editing revolution
The race to build better CRISPR delivery vehicles is heating up
Meet the man who combines science, technology and magic to understand proteins
AI gene editing tools have power to modify human DNA, say researchers
AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality
How crops are being disaster-proofed
